On May 13, 2020, AbCellera Biologics, Inc. (NASDAQ:ABCL), a biopharmaceutical company based in Vancouver, British Columbia, announced the results of its first quarter of 2020 financial results.  The company announced the results of its first quarter of 2020 business update on May 13, 2020.  According to the company's prepared remarks, the company's business model is about building out the technology stack to enable it to deliver on its long-term goals.  The company's first quarter financial results, which were released on May 13, 2020, showed a 63% increase in the number of programs under contract.  The company's second quarter financial results, which were also the company's first quarter of 2020, showed a 63% increase in programs under contract.  The company's first quarter financial results were down from the prior quarter.  The company's second quarter financial results were down from the first quarter of 2020.  The company's third quarter financial results, which were down from the first quarter of 2020, were down from the second quarter of 2020.  The company's fourth quarter financial results, which were down from the second quarter of 2020, were down from the third quarter of 2020.  The company's second quarter financial results are down from the first quarter of 2020, and the company's first quarter financial results are down from the second quarter of 2020.  In a parallel development, AbCellera announced the acquisition of Invetx, a company that has a long track record of acquiring and developing antibody therapies.  The company's first quarter financial results are up from the first quarter of 2020.  The second quarter financial results were down from the second quarter of 2020, and the company's first half of 2020 was down from the first quarter of 2020.  In the second quarter of 2020, the company announced that it had acquired Invetx, a company that had a long track record of acquiring antibody therapies.  The company's third quarter financial results were down from the first quarter.  The company's fourth quarter financial results were down from the first quarter, and the company's first half of 2020 is down from the second quarter.  The company's third quarter financial results are up from the first quarter.  The company's first half of 2020 financial results were down from the second quarter of 2019.  The company's first half of 2020 is up from the first half of 2020.  The company's second half of 2020 is up from the second half of 2020.  The company's first half of 2020 will be up from the first half of 2020, and the company's second half of 2020 will be up from the second half of 2019.  The company's second half of 2020 will be down from the first half of 2020.